Also available in Persian — نسخه فارسی EN فا
❓ Unknown

SBRT Enhances Bowel Quality of Life in Prostate Cancer Patients, Study Shows

3w ago August 26, 2026 1 min read 📰 Medical Xpress
📋 Key Takeaway

A clinical study found that stereotactic body radiation therapy (SBRT) significantly improved bowel health-related quality of life for patients with localized intermediate-risk prostate cancer compared to moderately hypofractionated intensity-modulated radiation therapy (MH-IMRT). The findings were presented at a major radiation oncology conference and published in JAMA. This research may have implications for cancer treatment protocols in Iran.

🔍 Quick Context Guide
💡 Bottom Line: The study highlights a promising treatment option that could improve the quality of life for prostate cancer patients.

👥 Key Players

NRG Oncology MENTIONED
Research organization conducting the study
"They are a key player in cancer research, influencing treatment protocols that could affect patient care in Iran."
American Society for Radiation Oncology MENTIONED
Professional organization hosting the annual meeting
"They set standards and guidelines for radiation oncology practices, impacting treatment options available in Iran."

📰 What Happened

A clinical study found that stereotactic body radiation therapy (SBRT) significantly improved bowel health-related quality of life for patients with localized intermediate-risk prostate cancer compared to moderately hypofractionated intensity-modulated radiation therapy (MH-IMRT). The findings were presented at a major conference and published in a leading medical journal.

  • SBRT showed significant improvement in bowel health-related quality of life.
  • There was no significant improvement in urinary health-related quality of life or disease-free survival.

💡 Why It Matters

🇮🇷 For Iran: Improved treatment options could enhance the quality of life for prostate cancer patients in Iran, where cancer care is a growing concern.
🌍 Regional: The findings may influence cancer treatment protocols across the Middle East, where prostate cancer rates are rising.
🌐 International: Internationally, this research could shift the standard of care for prostate cancer treatment, impacting global health policies.

📚 Background

Prostate cancer is one of the most common cancers among men, and treatment options can significantly affect patients' quality of life. SBRT is a newer radiation therapy that may offer benefits over traditional methods.

Prostate cancer treatment Radiation therapy advancements
📡 Source: NEUTRAL
📊 Confidence: 70%
The findings are published in a peer-reviewed journal, indicating a level of credibility and scientific rigor.

Results of the NRG Oncology NRG-GU005 clinical study comparing stereotactic body radiation therapy (SBRT) with moderately hypofractionated intensity-modulated radiation therapy (MH-IMRT) for patients with localized intermediate-risk prostate cancer indicate that SBRT improved bowel health-related quality of life (HRQOL) in this patient population. There was no significant improvement with SBRT in the other primary objectives, including urinary HRQOL and disease-free survival. These results are now published in the JAMA following their presentation during the Plenary Session of the 2025 American Society for Radiation Oncology Annual Meeting in San Francisco.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 100%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →